FizyoArt LogoFizyoArt

Önemli: Bu içerik kişisel tıbbi değerlendirme ve muayenenin yerine geçmez. Acil durumlarda önce doktor veya acil servise başvurun — 112.

Lung Volume Reduction Surgery

What is lung volume reduction surgery, who may be eligible, how is it performed, and what are the benefits and risks? A sourced patient guide.

Brief summary: Lung volume reduction surgery (LVRS) removes the most damaged and overinflated areas of the lung in selected patients with severe emphysema. The goal is not to operate on every person with COPD, but to improve breathlessness, exercise capacity, and selected outcomes in the right patient. [1][2]

What is lung volume reduction surgery?

Lung volume reduction surgery is the surgical removal of the most destroyed and hyperinflated parts of the lung. The aim is to allow relatively healthier lung tissue to work more efficiently, help the diaphragm regain mechanical advantage, and reduce the work of breathing. The procedure is considered most often in emphysema-predominant COPD, where loss of elastic recoil and air trapping are more prominent than airway narrowing alone. It does not eliminate the disease completely; the main goal is to reduce symptoms and improve functional capacity. [1][3][4][6]

Not every person with severe COPD or emphysema is a candidate. The success of LVRS depends heavily on correct patient selection. In clinical practice, patients with upper-lobe predominant disease and severe symptoms despite medical treatment and rehabilitation may benefit more. In contrast, homogeneous emphysema or advanced frailty may make the risk-benefit balance less favorable. Decision-making therefore depends not only on imaging, but also on lung function tests, exercise capacity, oxygen need, and overall surgical risk. [1][2][5][6]

Who may be considered for it?

LVRS is generally considered in people whose quality of life remains seriously impaired despite standard treatment such as medication, smoking cessation, vaccinations, management of oxygen needs, and pulmonary rehabilitation. Assessment includes the degree of air trapping, the distribution of emphysema, exercise performance, and coexisting cardiac or metabolic disease that may increase surgical risk. The operation should not be planned simply because a patient has shortness of breath; it should be evaluated systematically in an experienced center. [1][2][3][4]

Smoking status is a particularly important factor. Planning LVRS while a person continues to use tobacco is generally not appropriate, because surgical risk increases and protecting the remaining lung tissue becomes more difficult. In addition, some patients may be candidates for bronchoscopic lung volume reduction approaches based on similar principles. For that reason, the decision about LVRS is often made with input from pulmonology, thoracic surgery, radiology, rehabilitation, and anesthesia. Two people with the same diagnosis may have very different surgical suitability. [2][3][5][6]

Preoperative preparation and how the operation is done

Before surgery, detailed breathing tests, high-resolution CT, exercise evaluation, arterial blood gas measurements, and cardiac assessments may be performed. The expected limits of surgery should be explained as clearly as its potential benefits. LVRS is not a miracle cure that replaces COPD treatment; medications, rehabilitation, and lifestyle measures usually continue afterward. Pulmonary rehabilitation before surgery is important not only to improve conditioning, but also to prepare the patient for postoperative recovery. Learning breathing techniques, secretion clearance, and maintaining physical capacity can influence the outcome. [1][2][3][4]

The surgery may be performed through an open approach or through smaller incisions using video-assisted thoracoscopic surgery. The basic principle is removal of the most damaged, nonfunctioning lung areas. After the operation, chest tubes, pain control, early mobilization, and respiratory physiotherapy are central aspects of care. Air leak, atelectasis, infection, or fluctuation in oxygen need may occur in the early days. That is why postoperative management is almost as important as the surgical technique itself. Patients are usually re-entered into rehabilitation after surgery, because the real gain comes not only from the operation but from active recovery afterward. [1][3][5][6]

Potential benefits, risks, and recovery

In appropriately selected patients, LVRS may reduce breathlessness, improve exercise capacity, and enhance quality of life. The degree of benefit is not the same in everyone: some people experience marked relief, whereas others obtain more limited gains. The NETT trial and later studies clearly showed that patient selection determines outcome. For that reason, the key question is not merely whether surgery can technically be performed, but whether the expected benefit is likely to be meaningful in this specific patient. Surgery should be considered together with medication, exercise, and prevention of infection rather than as a separate solution. [2][3][5][6]

Risks include prolonged air leak, pneumonia, bleeding, arrhythmia, intensive care need, and, in some people, failure to achieve the hoped-for improvement. Surgical risk rises in people with very advanced COPD, severe weight loss, or major comorbidities. After discharge, increasing breathlessness, fever, new sputum change, severe chest pain, cyanosis, marked weakness, or dropping oxygen saturation require urgent assessment. LVRS is a selective procedure that should be considered only in the right person and with an experienced team; general conclusions should not be drawn without individualized risk analysis. [1][4][5][6]

Lung volume reduction surgery may be meaningful not for every patient with severe emphysema, but for a selected subgroup with specific characteristics. The safest approach is for people whose daily life is seriously limited by advanced COPD or emphysema to evaluate surgical and bronchoscopic volume reduction options together in an experienced center. [1][2][3]

For some patients, the success of surgery is measured not only by changes in lung function numbers, but also by daily life outcomes such as climbing stairs more easily, pausing less at home, leaving the house more often, and managing exacerbations more effectively. Follow-up should therefore consider both measurable values and the person’s lived experience. To preserve gains after surgery, remaining smoke-free, maintaining vaccination, and reporting infection signs early are essential. [1][2][3][4]

References

  1. 1.Mayo Clinic. Lung volume reduction surgery. https://www.mayoclinic.org/tests-procedures/lung-volume-reduction-surgery/about/pac-20385045
  2. 2.NHLBI. National Emphysema Treatment Trial (NETT). https://www.nhlbi.nih.gov/science/national-emphysema-treatment-trial-nett
  3. 3.American Lung Association. Lung Volume Reduction Surgery. https://www.lung.org/lung-health-diseases/lung-procedures-and-tests/lung-volume-reduction-surgery
  4. 4.MedlinePlus. Emphysema. https://medlineplus.gov/emphysema.html
  5. 5.PubMed. Lung volume reduction surgery beyond the NETT selection criteria. https://pubmed.ncbi.nlm.nih.gov/36246544/
  6. 6.PubMed. Lung volume reduction surgery in emphysema: a pragmatic review. https://pubmed.ncbi.nlm.nih.gov/38519285/

For more detailed information about this topic or to consult with our specialist physiotherapists, please contact us.

Contact Us